位置:首页 > 蛋白库 > I17RE_MOUSE
I17RE_MOUSE
ID   I17RE_MOUSE             Reviewed;         637 AA.
AC   Q8BH06; Q3I5F0; Q6NSU9; Q8C5D0; Q8K4C1; Q8R335;
DT   13-NOV-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 125.
DE   RecName: Full=Interleukin-17 receptor E;
DE            Short=IL-17 receptor E;
DE            Short=IL-17RE;
DE   Flags: Precursor;
GN   Name=Il17re;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), FUNCTION, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16310341; DOI=10.1016/j.cellsig.2005.10.010;
RA   Li T.-S., Li X.-N., Chang Z.-J., Fu X.-Y., Liu L.;
RT   "Identification and functional characterization of a novel interleukin 17
RT   receptor: a possible mitogenic activation through ras/mitogen-activated
RT   protein kinase signaling pathway.";
RL   Cell. Signal. 18:1287-1298(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Gilbert J.M., Gorman D.M.;
RT   "Identification of novel IL-17 related receptors.";
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 5).
RC   STRAIN=C57BL/6J;
RC   TISSUE=Adipose tissue, Colon, Corpora quadrigemina, and Thymus;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 5).
RC   STRAIN=C57BL/6J, and Czech II;
RC   TISSUE=Mammary tumor, and Olfactory epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, IDENTIFICATION AS IL17C RECEPTOR, INTERACTION WITH IL17RA, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=21982598; DOI=10.1016/j.immuni.2011.09.010;
RA   Chang S.H., Reynolds J.M., Pappu B.P., Chen G., Martinez G.J., Dong C.;
RT   "Interleukin-17C promotes Th17 cell responses and autoimmune disease via
RT   interleukin-17 receptor E.";
RL   Immunity 35:611-621(2011).
RN   [6]
RP   FUNCTION, IDENTIFICATION AS IL17C RECEPTOR, INTERACTION WITH IL17RA, TISSUE
RP   SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=21993849; DOI=10.1038/ni.2155;
RA   Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., Qian Y.;
RT   "IL-17RE is the functional receptor for IL-17C and mediates mucosal
RT   immunity to infection with intestinal pathogens.";
RL   Nat. Immunol. 12:1151-1158(2011).
RN   [7]
RP   TISSUE SPECIFICITY.
RX   PubMed=21993848; DOI=10.1038/ni.2156;
RA   Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J.,
RA   Hackney J., Kim J., Zhou M., Lai J., Modrusan Z., Sai T., Lee W., Xu M.,
RA   Caplazi P., Diehl L., de Voss J., Balazs M., Gonzalez L. Jr., Singh H.,
RA   Ouyang W., Pappu R.;
RT   "IL-17C regulates the innate immune function of epithelial cells in an
RT   autocrine manner.";
RL   Nat. Immunol. 12:1159-1166(2011).
CC   -!- FUNCTION: Specific functional receptor for IL17C, signaling through the
CC       NF-kappa-B and MAPK pathways. Requires TRAF3IP2 /ACT1 for signaling.
CC       Crucial regulator in innate immunity to bacterial pathogens, such as
CC       Citrobacter rodentium. Isoform 4 and isoform 5 may be either
CC       cytoplasmic inactive or dominant active forms. Isoform 2 and isoform 3
CC       may act as soluble decoy receptors. {ECO:0000269|PubMed:16310341,
CC       ECO:0000269|PubMed:21982598, ECO:0000269|PubMed:21993849}.
CC   -!- SUBUNIT: Forms heterodimers with IL17RA; the heterodimer binds IL17C.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Single-pass type I
CC       membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 5]: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=IL-17RE1, IL17RE-S;
CC         IsoId=Q8BH06-1; Sequence=Displayed;
CC       Name=2; Synonyms=IL-17RE2;
CC         IsoId=Q8BH06-2; Sequence=VSP_029200;
CC       Name=3; Synonyms=IL-17RE3;
CC         IsoId=Q8BH06-3; Sequence=VSP_029199;
CC       Name=4; Synonyms=IL-17RE4, IL-17RE5, IL17RE-S;
CC         IsoId=Q8BH06-4; Sequence=VSP_029198;
CC       Name=5; Synonyms=IL-17RE6;
CC         IsoId=Q8BH06-5; Sequence=VSP_029197;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in mucosal tissues,
CC       including trachea, lung, kidney and stomach. Highly expressed in colon
CC       epithelial cells. Also expressed in testis. Low expression, if any, in
CC       heart, liver, spleen, or brain. Among CD4 T-helper cells, expressed at
CC       high levels in Th17 cells. {ECO:0000269|PubMed:16310341,
CC       ECO:0000269|PubMed:21982598, ECO:0000269|PubMed:21993848,
CC       ECO:0000269|PubMed:21993849}.
CC   -!- DEVELOPMENTAL STAGE: Expression starts at 10.5 dpc and reaches a
CC       plateau of expression at 12.5 dpc. {ECO:0000269|PubMed:16310341}.
CC   -!- INDUCTION: Up-regulated by its own ligand IL17C. Also up-regulated by
CC       IL6 and TNF acting synergically. This induction can be further
CC       increased by IL23. {ECO:0000269|PubMed:21982598}.
CC   -!- DISRUPTION PHENOTYPE: Mutant animals are born normally at the expected
CC       Mendelian frequency. They exhibit much lower expression of genes
CC       encoding antibacterial molecules, much greater bacterial burdens and
CC       total mortality after infection with Citrobacter rodentium.
CC       {ECO:0000269|PubMed:21993849}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC37436.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ092339; AAZ85958.1; -; mRNA.
DR   EMBL; DQ092340; AAZ85959.1; -; mRNA.
DR   EMBL; DQ092341; AAZ85960.1; -; mRNA.
DR   EMBL; AF458068; AAM77572.1; -; mRNA.
DR   EMBL; AK046302; BAC32678.1; -; mRNA.
DR   EMBL; AK046713; BAC32842.1; -; mRNA.
DR   EMBL; AK078876; BAC37436.1; ALT_FRAME; mRNA.
DR   EMBL; AK169498; BAE41201.1; -; mRNA.
DR   EMBL; BC026737; AAH26737.1; -; mRNA.
DR   EMBL; BC069861; AAH69861.1; -; mRNA.
DR   CCDS; CCDS20420.1; -. [Q8BH06-1]
DR   CCDS; CCDS20421.1; -. [Q8BH06-4]
DR   CCDS; CCDS90101.1; -. [Q8BH06-2]
DR   CCDS; CCDS90102.1; -. [Q8BH06-3]
DR   RefSeq; NP_001029201.1; NM_001034029.1. [Q8BH06-4]
DR   RefSeq; NP_001029203.1; NM_001034031.1. [Q8BH06-4]
DR   RefSeq; NP_665825.2; NM_145826.5. [Q8BH06-1]
DR   AlphaFoldDB; Q8BH06; -.
DR   SMR; Q8BH06; -.
DR   IntAct; Q8BH06; 2.
DR   STRING; 10090.ENSMUSP00000062103; -.
DR   GlyGen; Q8BH06; 2 sites.
DR   PhosphoSitePlus; Q8BH06; -.
DR   MaxQB; Q8BH06; -.
DR   PaxDb; Q8BH06; -.
DR   PRIDE; Q8BH06; -.
DR   ProteomicsDB; 273077; -. [Q8BH06-1]
DR   ProteomicsDB; 273078; -. [Q8BH06-2]
DR   ProteomicsDB; 273079; -. [Q8BH06-3]
DR   Antibodypedia; 2563; 324 antibodies from 31 providers.
DR   DNASU; 57890; -.
DR   Ensembl; ENSMUST00000053569; ENSMUSP00000054378; ENSMUSG00000043088. [Q8BH06-4]
DR   Ensembl; ENSMUST00000058548; ENSMUSP00000062103; ENSMUSG00000043088. [Q8BH06-1]
DR   Ensembl; ENSMUST00000101065; ENSMUSP00000098626; ENSMUSG00000043088. [Q8BH06-4]
DR   Ensembl; ENSMUST00000203661; ENSMUSP00000145345; ENSMUSG00000043088. [Q8BH06-3]
DR   Ensembl; ENSMUST00000204774; ENSMUSP00000145384; ENSMUSG00000043088. [Q8BH06-2]
DR   GeneID; 57890; -.
DR   KEGG; mmu:57890; -.
DR   UCSC; uc009dgg.1; mouse. [Q8BH06-1]
DR   UCSC; uc009dgj.1; mouse. [Q8BH06-5]
DR   CTD; 132014; -.
DR   MGI; MGI:1889371; Il17re.
DR   VEuPathDB; HostDB:ENSMUSG00000043088; -.
DR   eggNOG; ENOG502QU0I; Eukaryota.
DR   GeneTree; ENSGT00940000161421; -.
DR   HOGENOM; CLU_026094_0_0_1; -.
DR   InParanoid; Q8BH06; -.
DR   OMA; RIHATFS; -.
DR   OrthoDB; 238258at2759; -.
DR   PhylomeDB; Q8BH06; -.
DR   TreeFam; TF335690; -.
DR   BioGRID-ORCS; 57890; 1 hit in 73 CRISPR screens.
DR   ChiTaRS; Il17re; mouse.
DR   PRO; PR:Q8BH06; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; Q8BH06; protein.
DR   Bgee; ENSMUSG00000043088; Expressed in vestibular membrane of cochlear duct and 113 other tissues.
DR   ExpressionAtlas; Q8BH06; baseline and differential.
DR   Genevisible; Q8BH06; MM.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030368; F:interleukin-17 receptor activity; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   InterPro; IPR039465; IL-17_rcpt-like.
DR   InterPro; IPR027841; IL-17_rcpt_C/E_N.
DR   InterPro; IPR013568; SEFIR_dom.
DR   PANTHER; PTHR15583; PTHR15583; 2.
DR   Pfam; PF15037; IL17_R_N; 2.
DR   Pfam; PF08357; SEFIR; 1.
DR   PROSITE; PS51534; SEFIR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Glycoprotein;
KW   Inflammatory response; Membrane; Receptor; Reference proteome; Secreted;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..637
FT                   /note="Interleukin-17 receptor E"
FT                   /id="PRO_0000309468"
FT   TOPO_DOM        24..414
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        415..435
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        436..637
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          447..583
FT                   /note="SEFIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00867"
FT   REGION          87..134
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        87..113
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        278
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..326
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_029197"
FT   VAR_SEQ         1..201
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16310341"
FT                   /id="VSP_029198"
FT   VAR_SEQ         410..455
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_029199"
FT   VAR_SEQ         410..442
FT                   /note="VSHRHLGLLILALLALTALVGVVLVLLGRRLLP -> DAPYPTQLLLRSL
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_029200"
FT   CONFLICT        377
FT                   /note="T -> M (in Ref. 4; AAH26737)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="H -> Q (in Ref. 4; AAH26737)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        543
FT                   /note="A -> P (in Ref. 3; BAC37436)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   637 AA;  70833 MW;  5BFD2AB5128BB758 CRC64;
     MGSPRLAALL LSLPLLLIGL AVSARVACPC LRSWTSHCLL AYRVDKRFAG LQWGWFPLLV
     RKSKSPPKFE DYWRHRTPAS FQRKLLGSPS LSEESHRISI PSSAISHRGQ RTKRAQPSAA
     EGREHLPEAG SQKCGGPEFS FDLLPEVQAV RVTIPAGPKA SVRLCYQWAL ECEDLSSPFD
     TQKIVSGGHT VDLPYEFLLP CMCIEASYLQ EDTVRRKKCP FQSWPEAYGS DFWQSIRFTD
     YSQHNQMVMA LTLRCPLKLE ASLCWRQDPL TPCETLPNAT AQESEGWYIL ENVDLHPQLC
     FKFSFENSSH VECPHQSGSL PSWTVSMDTQ AQQLTLHFSS RTYATFSAAW SDPGLGPDTP
     MPPVYSISQT QGSVPVTLDL IIPFLRQENC ILVWRSDVHF AWKHVLCPDV SHRHLGLLIL
     ALLALTALVG VVLVLLGRRL LPGSGRTRPV LLLHAADSEA QRRLVGALAE LLRTALGGGR
     DVIVDLWEGT HVARIGPLPW LWAARERVAR EQGTVLLLWN CAGPSTACSG DPQAASLRTL
     LCAAPRPLLL AYFSRLCAKG DIPRPLRALP RYRLLRDLPR LLRALDAQPA TLASSWSHLG
     AKRCLKNRLE QCHLLELEAA KDDYQGSTNS PCGFSCL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024